Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Introduction And Importance: Uterine leiomyosarcoma (uLMS) is a rare and highly aggressive malignancy of the uterine myometrium, accounting for only 1-2% of uterine cancers. Due to its nonspecific presentation and the difficulty in distinguishing it from benign conditions, preoperative diagnosis remains challenging. Advanced diagnostic tools and clinical vigilance are crucial to improving outcomes for affected patients.

Case Presentation: A 39-year-old woman with a 3-year history of progressive abdominal pain and a palpable mass was diagnosed with a large uterine mass. Imaging suggested a pedunculated leiomyoma with potential malignant features. Exploratory laparotomy revealed a mass compressing adjacent structures, which was completely resected. Histopathology confirmed uLMS. The patient recovered well and had no recurrence at 6 months of follow-up.

Clinical Discussion: This case underscores the diagnostic and therapeutic challenges of uLMS, which often mimics benign leiomyomas on imaging. Surgical resection remains the cornerstone of treatment, with histopathological confirmation being essential for diagnosis. Adjuvant therapies have limited efficacy, highlighting the need for personalized management strategies.

Conclusion: Early diagnosis and timely surgical intervention are essential for optimal management of uLMS. The development of improved diagnostic modalities and targeted therapies is necessary to enhance patient outcomes for this rare malignancy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12369748PMC
http://dx.doi.org/10.1097/MS9.0000000000003355DOI Listing

Publication Analysis

Top Keywords

uterine leiomyosarcoma
8
uterine
5
unveiling hidden
4
hidden aggression
4
aggression rare
4
rare case
4
case uterine
4
diagnostic
4
leiomyosarcoma diagnostic
4
diagnostic dilemmas
4

Similar Publications

Rationale: Intravascular/intravenous leiomyomatosis (IVL) is a rare benign smooth muscle cell tumor with malignant biological behavior. The early diagnosis of IVL is challenging, and the range of treatment options is extensive.

Patient Concerns: Herein, we present 2 cases of IVL that present markedly different clinical presentations.

View Article and Find Full Text PDF

Background: Trophoblastic differentiation or beta-human chorionic gonadotropin (β-hCG) secretion in endometrial carcinoma has been associated with poorly differentiated and aggressive tumors; however, the evidence is largely inconclusive. The review aimed to explore the prognostic role of trophoblastic differentiation and β-hCG in non-trophoblastic, primary uterine corpus cancers.

Methodology: A comprehensive electronic search across databases was conducted for all cases of cancers of the uterine corpus that were either associated with elevated levels of β-hCG or showed evidence of trophoblastic differentiation upon microscopy or both.

View Article and Find Full Text PDF

Uterine leiomyosarcoma (uLMS) is a rare and deadly gynecologic malignancy. uLMS is histologically heterogeneous and presents with a wide spectrum of tumor differentiation, with a broad range of genomic DNA instability, which can make the diagnosis and prognosis of uLMS challenging. Methylation has emerged as a useful molecular tool in tumor classification and diagnosis in certain neoplasms.

View Article and Find Full Text PDF

Uterine leiomyomas (ULM) and uterine leiomyosarcomas (ULMS) represent smooth muscle tumors with similar initial presentations but drastically different outcomes. This literature review analyzes the similarities and differences in their epigenetic profiles to identify diagnostic biomarkers and potential therapeutic targets that could improve clinical management. Both tumor types exhibit mostly distinct epigenetic signatures while sharing key pathway dysregulations.

View Article and Find Full Text PDF